Search

Your search keyword '"Tulasne, David"' showing total 296 results

Search Constraints

Start Over You searched for: Author "Tulasne, David" Remove constraint Author: "Tulasne, David"
296 results on '"Tulasne, David"'

Search Results

1. ADAM30 Downregulates APP-Linked Defects Through Cathepsin D Activation in Alzheimer's Disease

7. MET variants with activating N-lobe mutations identified in hereditary papillary renal cell carcinomas still require ligand stimulation

11. Transforming properties of MET receptor exon 14 skipping can be recapitulated by loss of the CBL ubiquitin ligase binding site

12. MET exon 14 skipping mutation is a hepatocyte growth factor (HGF)‐dependent oncogenic driver in vitro and in humanised HGF knock‐in mice

13. Prolonging lung cancer response to EGFR inhibition by targeting the selective advantage of resistant cells

17. Supplementary Figure S6 from Functional Analysis of Somatic Mutations Affecting Receptor Tyrosine Kinase Family in Metastatic Colorectal Cancer

20. Data from Functional Analysis of Somatic Mutations Affecting Receptor Tyrosine Kinase Family in Metastatic Colorectal Cancer

21. Supplementary Table S1 from Functional Analysis of Somatic Mutations Affecting Receptor Tyrosine Kinase Family in Metastatic Colorectal Cancer

34. Novel germline MET pathogenic variants in French patients with papillary renal cell carcinomas type I

39. Germline MET pathogenic variants in papillary renal cell carcinomas type I: specific phenotype in French population and novel germline pathogenic variant MET c.3389T>C, p.(Leu1130Ser)

41. High MET Overexpression Does Not Predict the presence of MET exon 14 Splice Mutations in NSCLC: Results From the IFCT PREDICT.amm study

44. Abstract 3683: MET exon 14 skipping mutations in lung cancer: Screening, functional and clinical impact

45. 2,6-Diaminopurine as a highly potent corrector of UGA nonsense mutations

Catalog

Books, media, physical & digital resources